Pseudomonas aeruginosa
Pseudomonas aeruginosa is a bacterial strain commonly used in laboratory settings. It is a Gram-negative, rod-shaped bacterium that can be cultivated for various research and testing purposes. This product provides a stable and reliable source of the Pseudomonas aeruginosa strain for use in controlled experiments and analyses.
Lab products found in correlation
14 protocols using pseudomonas aeruginosa
Modulating Neutrophil Apoptosis in LPS-Induced Lung Injury
Grasshopper Bioactive Compounds Extraction and Characterization
Folin–Ciocalteu reagent, gallic acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH•), 2,2′-azinobis-(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS•+), (S)-6-methoxy-2,5,7,8-tetramethylchromane-2-carboxylic acid trolox (Sigma Aldrich), serine endoprotease from Bacillus licheniformis 2.4L E.C.3.4.21.14 (Sigma Aldrich), Luria Agar, Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Enterobacter aerogenes ATCC 13048 Salmonella sp., and Pseudomonas aeruginosa ATCC 77853 were used in this study. Samples of EG, AG, early grasshopper extract (EGE), adult grasshopper extract (AGE), early grasshopper hydrolysate (EGH), adult grasshopper hydrolysate (AGH), and hydrolyzed fractions were tested in this research.
Nanofiber-Mediated Immunomodulation in Endodontic Infection
Bacterial LPS and MIPS-9451 Synthesis
Antimicrobial Evaluation of M. oleifera Extracts
Oropharyngeal Exposure of C57BL/6J Mice
purchased from Envigo, UK. The mice treatment was randomized, and
animals were kept in groups of four in ventilated cages with ad libitum access to food and water in a controlled environment
(humidity, temperature, and light). All procedures were conducted
after ethical approval from the UK Home Office, under Project License
no. P089E2E0A. Following a week of acclimatization, the animals were
exposed to a solution of 1 μg/μL (30 μg of materials
in 30 μL of 0.5 % bovine serum albumin (BSA; Gibco, ThermoFisherScientific)
in water for injection (v/v)) or controls (negative: vehicle, Pseudomonas aeruginosa; Merck-Sigma) 0.5 mg/kg) by single
oropharyngeal aspiration. For the procedure, the mice were anesthetized
by inhalation of 3% isoflurane in 100% oxygen and then held on a slanted
board to deliver the materials or controls. The animals (n = 5) were kept for 1, 7, or 28 days after exposure. LPS 0.5 mg/kg
delivered via oropharyngeal aspiration was used as a positive control
to induce acute inflammation. Methylmethanesulfonate (MMS; Merck-Sigma;
3 × 150 mg/kg; n = 3; provided by gavage, 48,
24, and 4 h before sacrifice) was used as a positive control for DNA
damage.
Antimicrobial Chitosan Nanocomposite Synthesis
Bacterial Cultures for Immune Induction
Differentiation and Treatment of THP-1 Macrophages
Burn Wound Infection by Pseudomonas
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!